SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration
Under Section 12(g) of the Securities Exchange Act of 1934
or Suspension of Duty to File Reports Under Sections 13 and
15(d) of the Securities Exchange Act of 1934
Commission File Number 0-7623
Neutrogena Corporation
(Exact name of registrant as specified in its charter)
5760 West 96th Street
Los Angeles, California 90045
(310) 642-1150
(Address, including zip code, and telephone number,
including area code, of registrant's principal
executive offices)
Common Stock ($.001 par value)
Series A Preferred Stock ($.001 par value)
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty
to file reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the
appropriate rule provision(s) relied upon to terminate or
suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 15d-6 [ ]
Rule 12h-3(b)(1)(i) [X]
Approximate number of holders of record as of the
certification or notice date: 1
Pursuant to the requirements of the Securities
Exchange Act of 1934, Neutrogena Corporation has caused this
<PAGE>2
certification/notice to be signed on its behalf by the
undersigned duly authorized person.
Date: October 5, 1994 By: /s/ Dasha Lewin
Name: Dasha Lewin
Title: Vice President, Treasurer
and Corporate Secretary
